XPhyto Therapeutics Corp. announced two key appointments to continue its focus on research, development and commercialization of its biosensor and diagnostic products including for the detection of COVID-19. Director of Business Development:- Mr. Roland Spleiss has joined as the Director of Business Development.

Head of Diagnostic Research:- Mr. Spleiss is a seasoned commercial professional with over 25 years of experience in planning and building out effective salesforces, strategic realignment, production relocation, and project management, which makes him ideally suited to drive product sales. Mr. Spleiss' expertise in production and supply chain management, cost optimization, and sales force and distribution network creation will be invaluable to XPhyto's commercial strategy and execution. Dr. Heinrich Jehle has joined XPhyto as Head of Diagnostic Research.

Dr. Jehle has over 20 years' experience in the research and development of innovative medical screening tests and diagnostics. Previously, Dr. Jehle held senior roles in project management and research & development at leading European biotech and diagnostics companies.